TXMD · TherapeuticsMD, Inc. · Held by Funds
$2.16
+0.06 (+2.86%)
At close · Sep 11
View the 10-Q filed Aug 11, 2026
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The potential impact of these factors in conjunction with the uncertainty of the capital markets raises substantial doubt about our ability to continue as a going concern for the next twelve months from the issuance of these financial statements.”View the 10-Q filed Aug 11, 2026
Customer concentration
— top 3 customers 100% of revenue
3 customers — 100% of revenue (the three and six months ended June 30, 2026)
“For the three and six months ended June 30, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Market Cap
$25.00M
Shares
11.57M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding TXMD
16 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 244,317 | $539,941 | 0.00% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 109,380 | $241,730 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 65,183 | $139,492 | 0.00% | Long | 2026-05-31 | |
| Ultra-Small Company Market Fund | BRSIX | 17,000 | $37,570 | 0.03% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 15,320 | $32,785 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 14,835 | $31,747 | 0.00% | Long | 2026-05-31 | |
| ProShares UltraPro Nasdaq Biotechnology | — | 6,288 | $10,627 | 0.05% | Long | 2020-02-29 | |
| Dimensional U.S. Core Equity 2 ETF | DFAC | 4,826 | $9,845 | 0.00% | Long | 2026-04-30 | |
| The Gabelli ABC Fund | — | 3,600 | $7,956 | 0.00% | Long | 2026-06-30 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 9,700 | $7,192 | 0.10% | Long | 2021-09-30 | |
| Principal U.S. Small-MidCap Multi-Factor ETF | — | 2,607 | $4,119 | 0.04% | Long | 2020-09-30 | |
| Enterprise Mergers and Acquisitions Fund | — | 1,000 | $2,210 | 0.00% | Long | 2026-06-30 | |
| U.S. CORE EQUITY 1 PORTFOLIO | DFEOX | 1,063 | $2,169 | 0.00% | Long | 2026-04-30 | |
| Diversified Equity Alpha Master Portfolio | — | 745 | $1,646 | 0.00% | Long | 2026-06-30 | |
| U.S. CORE EQUITY 2 PORTFOLIO | DFQTX | 418 | $853 | 0.00% | Long | 2026-04-30 | |
| Guggenheim Active Allocation Fund | GUG | 46 | $98 | 0.00% | Long | 2026-05-29 |
Showing 1–16 of 16 positions